Isoflavone intake and risk of gastric cancer

A population-based prospective cohort study in Japan

Azusa Hara, Shizuka Sasazuki, Manami Inoue, Motoki Iwasaki, Taichi Shimazu, Norie Sawada, Taiki Yamaji, Shoichiro Tsugane

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Isoflavones are structurally similar to 17β-estradiol and may be able to prevent gastric cancer. However, there is contradictory evidence concerning the relation between the intake of soy food, which is rich in isoflavones, and gastric cancer. The association with gastric cancer might differ between isoflavones and soy foods, and research on the effects of isoflavone intake alone on gastric cancer is needed. Objective: We investigated the association between isoflavone intake and the incidence of gastric cancer. Design: We conducted a large, population-based prospective study of 39,569 men and 45,312 women aged 45-74 y. Dietary soy and isoflavone intakes were measured by using a validated food-frequency questionnaire in 1995 and 1998. Results: During 806,550 person-years of follow-up, we identified 1249 new gastric cancer cases. Isoflavone intake was not associated with gastric cancer in either men or women. Compared with the lowest quartile, the HR and 95% CI for developing gastric cancer in the fourth quartile of isoflavone intake was 1.00 (0.81, 1.24) for men and 1.07 (0.77, 1.50) for women. In a stratified analysis by exogenous female hormones (women only), however, we found an increasing trend in risk of gastric cancer associated with higher isoflavone intakes among exogenous female hormone users (P-trend = 0.03) but not for nonusers (P-interaction = 0.04). Conclusion: The current study does not support the hypothesis that higher intakes of isoflavones prevent gastric cancer in either men or women.

Original languageEnglish
Pages (from-to)147-154
Number of pages8
JournalAmerican Journal of Clinical Nutrition
Volume95
Issue number1
DOIs
Publication statusPublished - 2012 Jan 1
Externally publishedYes

Fingerprint

Isoflavones
Stomach Neoplasms
Japan
Cohort Studies
Prospective Studies
Population
Soy Foods
Hormones
Estradiol
Food

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Isoflavone intake and risk of gastric cancer : A population-based prospective cohort study in Japan. / Hara, Azusa; Sasazuki, Shizuka; Inoue, Manami; Iwasaki, Motoki; Shimazu, Taichi; Sawada, Norie; Yamaji, Taiki; Tsugane, Shoichiro.

In: American Journal of Clinical Nutrition, Vol. 95, No. 1, 01.01.2012, p. 147-154.

Research output: Contribution to journalArticle

Hara, A, Sasazuki, S, Inoue, M, Iwasaki, M, Shimazu, T, Sawada, N, Yamaji, T & Tsugane, S 2012, 'Isoflavone intake and risk of gastric cancer: A population-based prospective cohort study in Japan', American Journal of Clinical Nutrition, vol. 95, no. 1, pp. 147-154. https://doi.org/10.3945/ajcn.111.020479
Hara, Azusa ; Sasazuki, Shizuka ; Inoue, Manami ; Iwasaki, Motoki ; Shimazu, Taichi ; Sawada, Norie ; Yamaji, Taiki ; Tsugane, Shoichiro. / Isoflavone intake and risk of gastric cancer : A population-based prospective cohort study in Japan. In: American Journal of Clinical Nutrition. 2012 ; Vol. 95, No. 1. pp. 147-154.
@article{b0d3d092fea545ab99af67693ddba319,
title = "Isoflavone intake and risk of gastric cancer: A population-based prospective cohort study in Japan",
abstract = "Background: Isoflavones are structurally similar to 17β-estradiol and may be able to prevent gastric cancer. However, there is contradictory evidence concerning the relation between the intake of soy food, which is rich in isoflavones, and gastric cancer. The association with gastric cancer might differ between isoflavones and soy foods, and research on the effects of isoflavone intake alone on gastric cancer is needed. Objective: We investigated the association between isoflavone intake and the incidence of gastric cancer. Design: We conducted a large, population-based prospective study of 39,569 men and 45,312 women aged 45-74 y. Dietary soy and isoflavone intakes were measured by using a validated food-frequency questionnaire in 1995 and 1998. Results: During 806,550 person-years of follow-up, we identified 1249 new gastric cancer cases. Isoflavone intake was not associated with gastric cancer in either men or women. Compared with the lowest quartile, the HR and 95{\%} CI for developing gastric cancer in the fourth quartile of isoflavone intake was 1.00 (0.81, 1.24) for men and 1.07 (0.77, 1.50) for women. In a stratified analysis by exogenous female hormones (women only), however, we found an increasing trend in risk of gastric cancer associated with higher isoflavone intakes among exogenous female hormone users (P-trend = 0.03) but not for nonusers (P-interaction = 0.04). Conclusion: The current study does not support the hypothesis that higher intakes of isoflavones prevent gastric cancer in either men or women.",
author = "Azusa Hara and Shizuka Sasazuki and Manami Inoue and Motoki Iwasaki and Taichi Shimazu and Norie Sawada and Taiki Yamaji and Shoichiro Tsugane",
year = "2012",
month = "1",
day = "1",
doi = "10.3945/ajcn.111.020479",
language = "English",
volume = "95",
pages = "147--154",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "1",

}

TY - JOUR

T1 - Isoflavone intake and risk of gastric cancer

T2 - A population-based prospective cohort study in Japan

AU - Hara, Azusa

AU - Sasazuki, Shizuka

AU - Inoue, Manami

AU - Iwasaki, Motoki

AU - Shimazu, Taichi

AU - Sawada, Norie

AU - Yamaji, Taiki

AU - Tsugane, Shoichiro

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Background: Isoflavones are structurally similar to 17β-estradiol and may be able to prevent gastric cancer. However, there is contradictory evidence concerning the relation between the intake of soy food, which is rich in isoflavones, and gastric cancer. The association with gastric cancer might differ between isoflavones and soy foods, and research on the effects of isoflavone intake alone on gastric cancer is needed. Objective: We investigated the association between isoflavone intake and the incidence of gastric cancer. Design: We conducted a large, population-based prospective study of 39,569 men and 45,312 women aged 45-74 y. Dietary soy and isoflavone intakes were measured by using a validated food-frequency questionnaire in 1995 and 1998. Results: During 806,550 person-years of follow-up, we identified 1249 new gastric cancer cases. Isoflavone intake was not associated with gastric cancer in either men or women. Compared with the lowest quartile, the HR and 95% CI for developing gastric cancer in the fourth quartile of isoflavone intake was 1.00 (0.81, 1.24) for men and 1.07 (0.77, 1.50) for women. In a stratified analysis by exogenous female hormones (women only), however, we found an increasing trend in risk of gastric cancer associated with higher isoflavone intakes among exogenous female hormone users (P-trend = 0.03) but not for nonusers (P-interaction = 0.04). Conclusion: The current study does not support the hypothesis that higher intakes of isoflavones prevent gastric cancer in either men or women.

AB - Background: Isoflavones are structurally similar to 17β-estradiol and may be able to prevent gastric cancer. However, there is contradictory evidence concerning the relation between the intake of soy food, which is rich in isoflavones, and gastric cancer. The association with gastric cancer might differ between isoflavones and soy foods, and research on the effects of isoflavone intake alone on gastric cancer is needed. Objective: We investigated the association between isoflavone intake and the incidence of gastric cancer. Design: We conducted a large, population-based prospective study of 39,569 men and 45,312 women aged 45-74 y. Dietary soy and isoflavone intakes were measured by using a validated food-frequency questionnaire in 1995 and 1998. Results: During 806,550 person-years of follow-up, we identified 1249 new gastric cancer cases. Isoflavone intake was not associated with gastric cancer in either men or women. Compared with the lowest quartile, the HR and 95% CI for developing gastric cancer in the fourth quartile of isoflavone intake was 1.00 (0.81, 1.24) for men and 1.07 (0.77, 1.50) for women. In a stratified analysis by exogenous female hormones (women only), however, we found an increasing trend in risk of gastric cancer associated with higher isoflavone intakes among exogenous female hormone users (P-trend = 0.03) but not for nonusers (P-interaction = 0.04). Conclusion: The current study does not support the hypothesis that higher intakes of isoflavones prevent gastric cancer in either men or women.

UR - http://www.scopus.com/inward/record.url?scp=84455160876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84455160876&partnerID=8YFLogxK

U2 - 10.3945/ajcn.111.020479

DO - 10.3945/ajcn.111.020479

M3 - Article

VL - 95

SP - 147

EP - 154

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 1

ER -